A clinical trial for a mall dosage aspirin prevention the recurrence of genital warts

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006912

Enrollment

Unknown

Registered

2015-08-11

Start date

2013-08-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

genital warts

Interventions

2:Oral aspirin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 100 cases that over 18 years old with genital warts

Exclusion criteria

Exclusion criteria: immunlogic, Hematologic, cadiacal, peptic diseases

Design outcomes

Primary

Measure	Time frame
recurrence rate;	—

Countries

China

Contacts

Public ContactLi Wang

pfkwangli@126.com+86 13612355358

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026